MedTrace Logo

ClariFix Cryoablation Clinical Study

NCT02820597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2019-10-21

Study results available
· View outcomes & findings →

Summary

This is a single-arm pilot study designed to evaluate the feasibility of cryoablation in the nasal passageway, using the ClariFix device, to reduce the symptoms of chronic rhinitis.

Conditions

  • Rhinitis

Interventions

DEVICE

ClariFix device

Sponsors & Collaborators

  • Arrinex, Inc.

    lead INDUSTRY

Principal Investigators

  • Jacob Johnson, MD · San Francisco Otolaryngology Medical Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-15
Primary Completion
2016-02-05
Completion
2016-07-20
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02820597 on ClinicalTrials.gov